CareDx
CDNA
$10.15
Share price
4.42%
Change (1 day)
20.98%
Change (1 year)
CareDx (CDNA) - Cash on Hand
Cash on Hand as of December 2023 : $0.23 B
According to CareDx's latest financial reports the company has $0.23 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
CareDx - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.23 B | -19.68% |
| 2022-12-31 | $0.29 B | -15.9% |
| 2021-12-31 | $0.34 B | 55.09% |
| 2020-12-31 | $0.22 B | 487.87% |
| 2019-12-31 | $38.22 M | -40.85% |
| 2018-12-31 | $64.61 M | 282.46% |
| 2017-12-31 | $16.89 M | -2.1% |
| 2016-12-31 | $17.25 M | -42.26% |
| 2015-12-31 | $29.88 M | -17.96% |
| 2014-12-31 | $36.43 M | 610.43% |
| 2013-12-31 | $5.12 M | -12.04% |
| 2012-12-31 | $5.83 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 T2 Biosystems
TTOO | $15.68 M | -93.34% | 🇺🇸 USA |
 Agios Pharmaceuticals
AGIO | $0.77 B | 230.02% | 🇺🇸 USA |
 Invitae
NVTA | $0.25 B | 8.14% | 🇺🇸 USA |